Pursuant to General Assembly resolution 68/300, the present report sets out the progress achieved since 2014 in the implementation of the outcome document of the high-level meeting of the General Assembly on the comprehensive review and assessment of the progress achieved in the prevention and control of non-communicable diseases and of the political declaration of the high-level meeting of the Assembly on the prevention and control of non-communicable diseases, in preparation for a comprehensive review and assessment in 2018 of the progress achieved in the prevention and control of non-communicable diseases.
In the report, it is underscored that action to realize the commitments made in 2011 and 2014 is inadequate, that the current level of progress is insufficient to meet target 3.4 of the Sustainable Development Goals on non-communicable diseases and that the world has yet to fulfil its promise of implementing measures to reduce the risk of dying prematurely from non-communicable diseases through prevention and treatment.
Initiatives to improve access to good-quality essential health-care services and to safe, effective, good-quality and affordable essential medicines and vaccines for the prevention and control of non-communicable diseases have not been scaled up in the majority of developing countries. Political commitments have often not been translated into concrete action. Serious constraints driven by economic and trade promotion interests are impeding the implementation by many Governments of some of the “best buys” and other recommended interventions for the prevention and control of non-communicable diseases, including the taxation of tobacco, alcohol and sugar-sweetened beverages and policies to reduce the impact on children of the marketing of foods and non-alcoholic beverages high in saturated fats, trans-fatty acids, free sugars or salt. There is also a visible gap in respect of each country’s policy space and leadership to establish and implement policies for the prevention and control of non-communicable diseases.